Cyber security (unauthorized access or unauthorized use of data or information) is a serious business and reputational risk facing life sciences companies. Given the ubiquity of technology, growing privacy cyber regulations and customer employee shareholder expectations, it is critical that biotech firms identify, manage and mitigate these exposures.
This session will feature a biotech firm, an attorney, a cyber insurance broker and underwriter. The panel will discuss exposures life sciences companies face (sensitive personal information which may be compromised), best practices to protect data from unauthorized access and strategies to respond appropriately if, despite a company's best efforts, they become a victim of a cyber attack.
Ability Level: Intermediate
Session ID: 21040